Optimistic study

potency prior to the intervention.

According to the Spanish Society of Medical Oncology (SEOM), cancer continues to be one of the main causes of morbidity and mortality in the world. In Spain, it is estimated that new cancer diagnoses will reach 279,260 cas­

100,000 es in 2023. Of these, prostate cancer is the most common among men.

In fact, the Cancer Centre of the Clinica Universidad de Navarra has been the first in Spain to offer the entire diagnostic and therapeutic arsenal for the management of benign and malignant prostate pathology, as reported by a national news outlet on Tuesday, February 14.